| 537 |
Estrogen receptor agonism leads to reduced fecundity via increased vitellogenin in the liver |
Brendan Ferreri-Hanberry |
BY-SA |
111: Agonism, Estrogen receptor
|
78: Reduction, Cumulative fecundity and spawning
|
|
|
| 538 |
Adverse outcome pathway of PFAS-induced vascular disrupting effects via activating oxidative stress related pathways |
Arthur Author |
All rights reserved |
None
|
2161: Increase, Vascular disrupting effects
|
|
|
| 539 |
Decreased Sodium/Potassium ATPase activity leads to Heart failure |
Agnes Aggy |
BY-SA |
1562: Decreased Na/K ATPase activity
|
1535: Heart failure
|
|
|
| 540 |
Oxidative Stress in the Fish Ovary Leads to Reproductive Impairment via Reduced Vitellogenin Production |
Allie Always |
All rights reserved |
1115: Increase, Reactive oxygen species
|
360: Decrease, Population growth rate
|
|
|
| 541 |
Excessive ROS generation leading to increased incidence of vascular calcification by VSMC phenotype switching |
Evgeniia Kazymova |
All rights reserved |
None
|
None
|
|
|
| 543 |
Inhibition of neuropathy target esterase leading to delayed neuropathy via lysolecithin cell membrane integration |
Cataia Ives |
All rights reserved |
2262: Neuropathy target esterase, inhibited
|
2267: Delayed neuropathy, increased
|
|
|
| 544 |
Inhibition of neuropathy target esterase leading to delayed neuropathy via increased inflammation |
Brendan Ferreri-Hanberry |
All rights reserved |
2262: Neuropathy target esterase, inhibited
|
2267: Delayed neuropathy, increased
|
|
|
| 545 |
Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis |
Arthur Author |
BY-SA |
239: Activation, Pregnane-X receptor, NR1l2
|
2271: Increased, plasma low-density lipoprotein (LDL) cholesterol
|
|
|
| 546 |
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms |
Agnes Aggy |
All rights reserved |
2118: Succinate dehydrogenase, inhibited
|
885: Increase, Cancer
|
|
|
| 547 |
Androgen receptor agonism leading to long anogenital distance in female offspring |
Allie Always |
All rights reserved |
25: Agonism, Androgen receptor
|
2365: Anogenital distance, increased
|
|
|
| 548 |
Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression |
Evgeniia Kazymova |
BY-SA |
239: Activation, Pregnane-X receptor, NR1l2
|
2271: Increased, plasma low-density lipoprotein (LDL) cholesterol
|
|
|
| 549 |
Aromatase inhibition leads to reproductive toxicity (including growth and developmental toxicity) in adult female zebrafish |
Cataia Ives |
BY-SA |
36: Inhibition, Aromatase
|
3 AOs
|
|
|
| 550 |
Increased LMNA gene mutation leading to heart failure |
Brendan Ferreri-Hanberry |
BY-SA |
2278: Increased LMNA Mutation
|
1535: Heart failure
|
|
|
| 551 |
Increased Muscarinic M2 Receptor leading to Arrhythmia |
Arthur Author |
Open for adoption |
1602: Increased Muscarinic Acetylcholine Receptors
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 552 |
Inhibiton of L-Type Calcium Channels leading to heart failure via QT interval prolongation and Torsades de Pointes (TdP) |
Agnes Aggy |
All rights reserved |
1529: Blockade, L-Type Calcium Channels
|
1535: Heart failure
|
|
|
| 553 |
Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure |
Allie Always |
All rights reserved |
584: Inhibition, sodium channel
|
1535: Heart failure
|
|
|
| 554 |
β-adrenergic receptor agonists leading to arrhythmias. |
Evgeniia Kazymova |
All rights reserved |
1038: Activation, beta-2 adrenergic receptor
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 555 |
Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure |
Cataia Ives |
All rights reserved |
593: Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel
|
1535: Heart failure
|
|
|
| 556 |
Decreased Na/K ATPase activity leading to heart failure |
Brendan Ferreri-Hanberry |
All rights reserved |
1562: Decreased Na/K ATPase activity
|
1535: Heart failure
|
|
|
| 557 |
β2-Receptor agonist leading to Cardiomyopathy |
Arthur Author |
All rights reserved |
1039: Increased activity, beta-2 adrenergic receptor
|
2157: Abnormal Cardiac Structure and Function
|
|
|
| 558 |
Phosphodiesterase inhibition leading to heart failure |
Agnes Aggy |
All rights reserved |
2288: Phosphodiesterase inhibition
|
1535: Heart failure
|
|
|
| 559 |
Inhibition of acetylcholinesterase (AChE) leading to arrhythmias |
Allie Always |
All rights reserved |
12: Acetylcholinesterase (AchE) Inhibition
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 560 |
Inhibition of Funny current (If) leading to Arrhythmias |
Evgeniia Kazymova |
Open for adoption |
2290: Inhibition of Funny current (If)
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 561 |
Aromatase induction leading to estrogen receptor alpha activation via increased estradiol |
Cataia Ives |
All rights reserved |
2293: Aromatase, induction
|
1065: Activation, estrogen receptor alpha
|
|
|
| 562 |
HCN Channel Inhibition leading to Arrhythmias |
Brendan Ferreri-Hanberry |
All rights reserved |
2295: HCN Channel Inhibition
|
1106: Occurrence, cardiac arrhythmia
|
|
|